02.03.11
Brigitte Genard has been named quality director at NextPharma Technologies' sterile contract development and manufacturing site in Braine-l’Alleud, Belgium. Ms. Genard will take responsibility for all aspects of quality across the site, including the recently FDA- and PDMA-inspected contract manufacturing plant which produces oncology products in commercial quantities and the Sterile Product Development Center.
Ms. Genard is an industrial pharmacist with 18 years of experience in Quality Assurance and Production. She has extensive experience in biopharmaceutical manufacturing, has worked for 15 years in industrial vaccine operations (bulk and secondary) and has previously worked for GSK Biologicals and UCB Bioproducts as senior quality assurance manager and head of production.
Bill Wedlake, NextPharma's chief executive officer, commented, "We are delighted to have Ms. Genard join our management team heading up the Quality function in Braine-l’Alleud. Her broad experience across our industry will enhance our ability to match the demands of our customers ensuring that NextPharma remains at the forefront of timely, competitive, healthcare outsourcing solutions of the highest quality."
Ms. Genard is an industrial pharmacist with 18 years of experience in Quality Assurance and Production. She has extensive experience in biopharmaceutical manufacturing, has worked for 15 years in industrial vaccine operations (bulk and secondary) and has previously worked for GSK Biologicals and UCB Bioproducts as senior quality assurance manager and head of production.
Bill Wedlake, NextPharma's chief executive officer, commented, "We are delighted to have Ms. Genard join our management team heading up the Quality function in Braine-l’Alleud. Her broad experience across our industry will enhance our ability to match the demands of our customers ensuring that NextPharma remains at the forefront of timely, competitive, healthcare outsourcing solutions of the highest quality."